Posted by Michael Wonder on 17 Jun 2026
Exdensur (depemokimab injection) approved in Canada for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps
16 June 2026 - GSK announced today that Health Canada has approved Exdensur (depemokimab) for two indications.
The approval is based on data from the positive SWIFT and ANCHOR Phase 3 trials.
